EAM Global Investors’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-16,774
Closed -$2M 150
2022
Q4
$2M Buy
+16,774
New +$2M 0.52% 70